EG639396 inhibitors are a class of small molecules that target specific biological pathways by inhibiting the activity of a particular protein or signaling molecule. These inhibitors have a defined structure that allows them to bind with high specificity and affinity to their target, typically resulting in the downregulation of certain cellular processes. Structurally, they often feature functional groups that facilitate their binding to the active site of their target, which could be an enzyme or a protein-protein interaction domain. The design and synthesis of EG639396 inhibitors involve considerations of molecular conformation, hydrophobicity, and electronic distribution to ensure optimal binding and inhibitory activity.
Chemically, EG639396 inhibitors can possess diverse scaffolds, which may include aromatic rings, heterocycles, and side chains that enhance their interaction with their specific protein targets. These inhibitors are typically developed through a series of structure-activity relationship (SAR) studies, aiming to optimize their potency, selectivity, and stability. They can act via competitive or non-competitive inhibition, often blocking the natural substrate or binding to an allosteric site to modulate the function of the protein. In research settings, EG639396 inhibitors are valuable tools for dissecting cellular signaling pathways and understanding protein function. Their application enables the study of biological processes at the molecular level, contributing to insights into protein mechanisms, structural biology, and the role of specific proteins in cellular physiology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $33.00 $64.00 | 11 | |
Inhibits NF-kB activation, which could indirectly affect Nedd4's role in protein ubiquitination. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can increase the levels of ubiquitinated proteins, potentially altering Nedd4-mediated pathways. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Another proteasome inhibitor that could lead to an accumulation of Nedd4 substrates by preventing their degradation. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Blocks epithelial Na+ channels and could modify Nedd4's role in sodium channel inhibitor activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that could influence Nedd4's role in dendrite morphogenesis and other processes. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $129.00 $214.00 $498.00 | 19 | |
A kinase inhibitor that could affect Nedd4's upstream regulation or activity by modulating phosphorylation events. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can impact the degradation of proteins ubiquitinated by Nedd4. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits autophagy which may lead to an increased load of ubiquitinated proteins, affecting Nedd4's processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could disrupt signaling pathways involving Nedd4. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A compound that can modulate various signaling pathways, potentially affecting Nedd4's regulatory functions. | ||||||